Fasudil hydrochloride injection composition and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANDONG NEWTIME PHARMA
- Publication Date
- 2015-08-19
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of medicine, in particular to a fasudil hydrochloride injection and a preparation method thereof. Background technique
[0002] Fasudil hydrochloride, the chemical name is hexahydro-1-(5-sulfonylisoquinoline)-1H-1,4-diazepine hydrochloride, and the molecular formula is C 14 h 17 N 3 o 2 S HCl, the molecular weight is 327.83, and the structural formula is
[0003] Fasudil hydrochloride is a new type of isoquinoline sulfonamide derivatives jointly developed by Asahi Kasei Pharmaceutical Co., Ltd. and the Pharmacology Laboratory of Nagoya University. It was officially approved for clinical use in Japan in 1995, and it was also used in China and other places later. Approved for marketing, for the prevention and treatment of chronic ischemic cerebral vasospasm.
[0004] Chinese Patent Application No. 201010617277.0 discloses a fasudil hydrochloride injection and its preparation method, which contains fasudil...